{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:19:00Z","timestamp":1755598740365},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,6]]},"DOI":"10.7759\/cureus.55655","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T16:10:02Z","timestamp":1709741402000},"source":"Crossref","is-referenced-by-count":1,"title":["The Role of Neoadjuvant Therapy in a Giant Gastric Gastrointestinal Stromal Tumour: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Jolan  S","family":"Alsaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saja","family":"Alruqayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Alomair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2009.108","article-title":"An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system","volume":"144","author":"Woodall CE 3rd","year":"2009","unstructured":"Woodall CE 3rd, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RC 2nd. An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg. 2009, 144:670-8. 10.1001\/archsurg.2009.108","journal-title":"Arch Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(03)01046-1","article-title":"Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors","volume":"125","author":"Hirota S","year":"2003","unstructured":"Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003, 125:660-7. 10.1016\/s0016-5085(03)01046-1","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200001000-00008","article-title":"Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival","volume":"231","author":"DeMatteo RP","year":"2000","unstructured":"DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000, 231:51-8. 10.1097\/00000658-200001000-00008","journal-title":"Ann Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(02)80601-3","article-title":"Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease","volume":"38 Suppl 5","author":"Roberts PJ","year":"2002","unstructured":"Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease. Eur J Cancer. 2002, 38 Suppl 5:S37-8. 10.1016\/s0959-8049(02)80601-3","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-7404(02)00074-9","article-title":"Gastrointestinal stromal tumors: a spectrum of disease","volume":"12","author":"Sturgeon C","year":"2003","unstructured":"Sturgeon C, Chejfec G, Espat NJ. Gastrointestinal stromal tumors: a spectrum of disease. Surg Oncol. 2003, 12:21-6. 10.1016\/s0960-7404(02)00074-9","journal-title":"Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri GD","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD, et al.. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002, 347:472-80. 10.1056\/NEJMoa020461","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.4403","article-title":"Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT","volume":"26","author":"Blanke CD","year":"2008","unstructured":"Blanke CD, Demetri GD, von Mehren M, et al.. Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol. 2008, 26:620-5. 10.1200\/JCO.2007.13.4403","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Dematteo RP","year":"2009","unstructured":"Dematteo RP, Ballman KV, Antonescu CR, et al.. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009, 373:1097-104. 10.1016\/S0140-6736(09)60500-6","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu H","year":"2012","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, et al.. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012, 307:1265-72. 10.1001\/jama.2012.347","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.9170","article-title":"Adjuvant imatinib for high-risk GI stromal tumor: analysis of a randomized trial","volume":"34","author":"Joensuu H","year":"2016","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, et al.. Adjuvant imatinib for high-risk GI stromal tumor: analysis of a randomized trial. J Clin Oncol. 2016, 34:244-50. 10.1200\/JCO.2015.62.9170","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153879","article-title":"Kit and PDGFRA variants and the survival of patients with gastrointestinal stromal tumor treated with adjuvant imatinib","volume":"15","author":"Joensuu H","year":"2023","unstructured":"Joensuu H. Kit and PDGFRA variants and the survival of patients with gastrointestinal stromal tumor treated with adjuvant imatinib. Cancers (Basel). 2023, 15:10.3390\/cancers15153879","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-12-47","article-title":"A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report","volume":"12","author":"Yanagawa S","year":"2014","unstructured":"Yanagawa S, Tanabe K, Suzuki T, Tokumoto N, Arihiro K, Ohdan H. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report. World J Surg Oncol. 2014, 12:47. 10.1186\/1477-7819-12-47","journal-title":"World J Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-019-00101-4","article-title":"Excision of a large gastrointestinal stromal tumour following 16 months of neoadjuvant therapy with imatinib (case report)","volume":"7","author":"Alassani F","year":"2019","unstructured":"Alassani F, Tchangai B, Bagny A, Adani-Ife AA, Amavi KA, Darre T, Attipou K. Excision of a large gastrointestinal stromal tumour following 16 months of neoadjuvant therapy with imatinib (case report). Oncol Ther. 2019, 7:159-64. 10.1007\/s40487-019-00101-4","journal-title":"Oncol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1456600","article-title":"Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: a case report and literature review","volume":"19","author":"Luo H","year":"2018","unstructured":"Luo H, Peng L, Wang N, et al.. Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: a case report and literature review. Cancer Biol Ther. 2018, 19:875-8. 10.1080\/15384047.2018.1456600","journal-title":"Cancer Biol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.08.20","article-title":"Gastrointestinal stromal tumors: a comprehensive review","volume":"10","author":"Parab TM","year":"2019","unstructured":"Parab TM, DeRogatis MJ, Boaz AM, et al.. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019, 10:144-54. 10.21037\/jgo.2018.08.20","journal-title":"J Gastrointest Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1532-1","article-title":"Gastrointestinal stromal tumor: clinicopathological characteristics and pathologic prognostic analysis","volume":"16","author":"Jumniensuk C","year":"2018","unstructured":"Jumniensuk C, Charoenpitakchai M. Gastrointestinal stromal tumor: clinicopathological characteristics and pathologic prognostic analysis. World J Surg Oncol. 2018, 16:231. 10.1186\/s12957-018-1532-1","journal-title":"World J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-023-01406-0","article-title":"Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach","volume":"26","author":"Kong SH","year":"2023","unstructured":"Kong SH, Kurokawa Y, Yook JH, et al.. Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach. Gastric Cancer. 2023, 26:775-87. 10.1007\/s10120-023-01406-0","journal-title":"Gastric Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103650","article-title":"Medical oncological treatment for patients with gastrointestinal stromal tumor (GIST) - a systematic review","volume":"172","author":"Brinch CM","year":"2022","unstructured":"Brinch CM, Aggerholm-Pedersen N, Hogdall E, Krarup-Hansen A. Medical oncological treatment for patients with gastrointestinal stromal tumor (GIST) - a systematic review. Crit Rev Oncol Hematol. 2022, 172:103650. 10.1016\/j.critrevonc.2022.103650","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref19","unstructured":"NCCN guidelines - gastrointestinal stromal tumors. (2023). https.\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1507."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-018-1737-5","article-title":"Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors","volume":"49","author":"Kaneko M","year":"2019","unstructured":"Kaneko M, Emoto S, Murono K, et al.. Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors. Surg Today. 2019, 49:460-6. 10.1007\/s00595-018-1737-5","journal-title":"Surg Today"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2018.01.01","article-title":"Neoadjuvant therapy for gastrointestinal stromal tumor","volume":"3","author":"Ishikawa T","year":"2018","unstructured":"Ishikawa T, Kanda T, Kameyama H, Wakai T. Neoadjuvant therapy for gastrointestinal stromal tumor. Transl Gastroenterol Hepatol. 2018, 3:3. 10.21037\/tgh.2018.01.01","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14056","article-title":"A giant gastric gastrointestinal stromal tumor successfully resected following neoadjuvant treatment with imatinib mesylate","volume":"40","author":"Takahashi R","year":"2020","unstructured":"Takahashi R, Toyokawa T, Yoshii M, et al.. A giant gastric gastrointestinal stromal tumor successfully resected following neoadjuvant treatment with imatinib mesylate. Anticancer Res. 2020, 40:1147-52. 10.21873\/anticanres.14056","journal-title":"Anticancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/gist-21-12","article-title":"Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report","volume":"5","author":"Kwon K","year":"2022","unstructured":"Kwon K, Iriarte F, Hartman H, Mittal J, Di Carlo A, Abbas A. Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report. Gastrointest Stromal Tumor. 2022, 5:10.21037\/gist-21-12","journal-title":"Gastrointest Stromal Tumor"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-6-76","article-title":"Spontaneous intratumoral bleeding and rupture of giant gastric stromal tumor (>30 cm) in a young patient","volume":"6","author":"Cruz RJ Jr","year":"2008","unstructured":"Cruz RJ Jr, Vincenzi R, Ketzer BM, Cecilio AL, Cepeda LA. Spontaneous intratumoral bleeding and rupture of giant gastric stromal tumor (>30 cm) in a young patient. World J Surg Oncol. 2008, 6:76. 10.1186\/1477-7819-6-76","journal-title":"World J Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-172","article-title":"Giant gastrointestinal stromal tumor (GIST) of the stomach cause of high bowel obstruction: surgical management","volume":"11","author":"Cappellani A","year":"2013","unstructured":"Cappellani A, Piccolo G, Card\u00ec F, et al.. Giant gastrointestinal stromal tumor (GIST) of the stomach cause of high bowel obstruction: surgical management. World J Surg Oncol. 2013, 11:172. 10.1186\/1477-7819-11-172","journal-title":"World J Surg Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2015.04.037","article-title":"A rare case of giant gastrointestinal stromal tumor of the stomach involving the serosal surface","volume":"12","author":"Koyuncuer A","year":"2015","unstructured":"Koyuncuer A, G\u00f6nl\u00fc\u015fen L, Kutsal AV. A rare case of giant gastrointestinal stromal tumor of the stomach involving the serosal surface. Int J Surg Case Rep. 2015, 12:90-4. 10.1016\/j.ijscr.2015.04.037","journal-title":"Int J Surg Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/215828-the-role-of-neoadjuvant-therapy-in-a-giant-gastric-gastrointestinal-stromal-tumour-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T16:10:06Z","timestamp":1709741406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/215828-the-role-of-neoadjuvant-therapy-in-a-giant-gastric-gastrointestinal-stromal-tumour-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.55655","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}